nach oben

Erschienen in:

01.07.2013 | Clinical Article - Brain Tumors

Tolerance of awake surgery for glioma: a prospective European Low Grade Glioma Network multicenter study

verfasst von: Thomas Beez, Kira Boge, Michel Wager, Ian Whittle, Denys Fontaine, Giannantonio Spena, Sebastian Braun, Andrea Szelényi, Lorenzo Bello, Hugues Duffau, Michael Sabel, for the European Low Grade Glioma Network

Erschienen in: Acta Neurochirurgica | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Gross total removal of glioma is limited by proximity to eloquent brain. Awake surgery allows for intraoperative monitoring to safely identify eloquent regions. However, data on adverse psychological effects induced in these patients is limited.

Objective

This study explored patients’ perception of awake surgery for glioma, with special focus on intraoperative pain and anxiety.

Methods

This study was conducted at five neurosurgical centers within the European Low Grade Glioma Network. Patients underwent awake surgery for glioma according to the protocol of the individual center. Pain and discomfort were measured during the awake phase. Postoperatively, patients answered a questionnaire on aspects of their operation.

Results

One hundred five patients were enrolled. Pain levels on a 10-cm visual analogue scale were 1.3 cm at the beginning, 1.9 cm the middle, and 2.1 cm at the end of awake phase. Levels of anxiety were 2.2 cm, 2.5 cm and 2.6 cm, respectively. Women and patients younger than 60 years exhibited highest mean anxiety levels. The patient questionnaire revealed that the majority of patients feel comfortable with the procedure. Discomfort resulted from head fixation or positioning on the operating table.

Conclusions

We demonstrate that awake surgery is well tolerated, as neither intraoperative nor postoperative assessment revealed major disadvantages. Concerning practical lessons learned from this study, we emphasize the importance of minimizing pain and preparing patients thoroughly to reduce anxiety and maximize cooperation. Awake surgery is an excellent treatment modality for brain tumors with very positive perception by patients.

Collins SL, Moore RA, McQuay HJ (1997) The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 72(1–2):95–97PubMedCrossRef

De Benedictis A, Moritz-Gasser S, Duffau H (2010) Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas. Neurosurgery 66(6):1074–1084, discussion 1084PubMedCrossRef

Duffau H (2009) A personal consecutive series of surgically treated 51 cases of insular WHO Grade II glioma: advances and limitations. J Neurosurg 110(4):696–708PubMedCrossRef

Duffau H (2012) Awake surgery for incidental WHO grade II gliomas involving eloquent areas. Acta Neurochir (Wien) 154(4):575–584, discussion 584CrossRef

Duffau H, Moritz-Gasser S, Gatignol P (2009) Functional outcome after language mapping for insular World Health Organization Grade II gliomas in the dominant hemisphere: experience with 24 patients. Neurosurg Focus 27(2):E7PubMedCrossRef

Gallagher EJ, Liebman M, Bijur PE (2001) Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 38(6):633–638PubMedCrossRef

Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W (2011) Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth 107(4):619–626PubMedCrossRef

Goebel S, Nabavi A, Schubert S, Mehdorn HM (2010) Patient perception of combined awake brain tumor surgery and intraoperative 1.5-T magnetic resonance imaging: the Kiel experience. Neurosurgery 67(3):594–600, discussion 600PubMedCrossRef

Goebel S, Stark A, Kaup L, von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psycho-Oncology 20(6):623–630PubMedCrossRef

10.

Khu KJ, Doglietto F, Radovanovic I, Taleb F, Mendelsohn D, Zadeh G, Bernstein M (2010) Patients’ perceptions of awake and outpatient craniotomy for brain tumor: a qualitative study. J Neurosurg 112(5):1056–1060PubMedCrossRef

11.

Kindler CH, Harms C, Amsler F, Ihde-Scholl T, Scheidegger D (2000) The visual analog scale allows effective measurement of preoperative anxiety and detection of patients’ anesthetic concerns. Anesth Analg 90(3):706–712PubMedCrossRef

12.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCrossRef

13.

Manninen PH, Balki M, Lukitto K, Bernstein M (2006) Patient satisfaction with awake craniotomy for tumor surgery: a comparison of remifentanil and fentanyl in conjunction with propofol. Anesth Analg 102(1):237–242PubMedCrossRef

14.

McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63(4):700–707, author reply 707–8PubMedCrossRef

15.

Palese A, Skrap M, Fachin M, Visioli S, Zannini L (2008) The experience of patients undergoing awake craniotomy: in the patients’ own words. A qualitative study. Cancer Nursing 31(2):166–172PubMedCrossRef

16.

Sartorius C, Berger M (1998) Rapid termination of intraoperative stimulation-evoked seizures with application of cold Ringer’s lactate to the cortex: technical note. J Neurosurg 349–351

17.

Schlomer GL, Bauman S, Card NA (2010) Best practices for missing data management in counseling psychology. J Couns Psychol 57(1):1–10PubMedCrossRef

18.

Serletis D, Bernstein M (2007) Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors. J Neurosurg 107(1):1–6PubMedCrossRef

19.

Smits A, Duffau H (2011) Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery 68(5):1326–1333PubMed

20.

Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol Off J Eur Fed Neurol Soc 17(9):1124–1133

21.

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef

22.

Stummer W, Reulen H-J, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62(3):564–576, discussion 564–76PubMedCrossRef

23.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRef

24.

Stupp R, Tonn J-C, Brada M, Pentheroudakis G (2010) High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals Oncol Off J Eur Soc Med Oncol / ESMO 21 Suppl 5(Supplement 5):v190–3

25.

Szelényi A, Bello L, Duffau H, Fava E, Feigl GC, Galanda M, Neuloh G, Signorelli F, Sala F (2010) Intraoperative electrical stimulation in awake craniotomy: methodological aspects of current practice. Neurosurg Focus 28(2):E7PubMedCrossRef

26.

Szelényi A, Joksimovic B, Seifert V (2007) Intraoperative risk of seizures associated with transient direct cortical stimulation in patients with symptomatic epilepsy. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 24(1):39–43CrossRef

27.

Todd KH, Funk KG, Funk JP, Bonacci R (1996) Clinical significance of reported changes in pain severity. Ann Emerg Med 27(4):485–489PubMedCrossRef

28.

Wahab SS, Grundy PL, Weidmann C (2011) Patient experience and satisfaction with awake craniotomy for brain tumours. Br J Neurosurg 25(5):606–613PubMedCrossRef

29.

Whittle IR, Midgley S, Georges H, Pringle A-M, Taylor R (2005) Patient perceptions of “awake” brain tumour surgery. Acta Neurochir (Wien) 147(3):275–277, discussion 277CrossRef

30.

Yordanova YN, Moritz-Gasser S, Duffau H (2011) Awake surgery for WHO Grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection. Clinical article. J Neurosurg 115(2):232–239PubMedCrossRef

31.

Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10(1):19–28PubMedCrossRef

Titel: Tolerance of awake surgery for glioma: a prospective European Low Grade Glioma Network multicenter study
verfasst von: Thomas Beez
Kira Boge
Michel Wager
Ian Whittle
Denys Fontaine
Giannantonio Spena
Sebastian Braun
Andrea Szelényi
Lorenzo Bello
Hugues Duffau
Michael Sabel
for the European Low Grade Glioma Network
Publikationsdatum: 01.07.2013
Verlag: Springer Vienna
Erschienen in: Acta Neurochirurgica / Ausgabe 7/2013
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-013-1759-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2013

Impact of anterior clinoidectomy on visual function after resection of meningiomas in and around the optic canal

The role of stereotactic radiosurgery for multiple brain metastases in stable systemic disease: a review of the literature

The medial loop of the V2 segment of the vertebral artery and the importance of this variation in correlation with the resection safe zone and technical characteristics of spinal cages during anterior cervical approaches

Comparative effectiveness of PEEK rods versus titanium alloy rods in lumbar fusion: A preliminary report

Syndromic versus nonsyndromic atlantoaxial dislocation: do clinico-radiological differences have a bearing on management?